EP3856341
Kristallað form af (S)-1-(4-flúorófenýl)-1-(2-(4-(6-(1-metýl-1h-pýrasól-4-ýl)pyrróló[2,1-f][1,2,4]tríasín-4-ýl)píperasínýl)-pýrimídín-5-ýl)etan-1-amín og aðferðir við gerð þess
:
EP einkaleyfi í gildi á Íslandi:
10.4.2020:
6.9.2023:
20722936.0
:
29.11.2023:
15.1.2024
:
9.4.2040:
9.4.2026:
30.4.2026
:
CRYSTALLINE FORMS OF (S)-1-(4-FLUOROPHENYL)-1-(2-(4-(6-(1-METHYL-1H-PYRAZOL-4-YL)PYRROLO[2,1-F][1,2,4]TRIAZIN-4-YL)PIPERAZINYL)-PYRIMIDIN-5-YL)ETHAN-1-AMINE AND METHODS OF MAKING
10.4.2020
6.9.2023
29.11.2023
15.1.2024
9.4.2026
:
Blueprint Medicines Corporation:
45 Sidney Street, Cambridge, MA 02139, US
:
WAETZIG, Joshua, D.:
Cambridge, MA 02139, US
:
MAR, Brenton:
Cambridge, MA 02139, US
:
HEINRICH, Brian:
Cambridge, MA 02139, US
:
WILKIE, Gordon:
Cambridge, MA 02139, US
:
MACEACHERN, Lauren:
Dartmouth, Nova Scotia, B2Y4C3, CA
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113, Reykjavík,
:
201962833527 P:
12.4.2019:
US
:
201962844575 P:
7.5.2019:
US
:
202062990269 P:
16.3.2020:
US
:
US2020027724:
10.4.2020
:
A61P 17/00, A61P 35/00, A61P 35/02, C07D 487/04, A61K 31/519
: 5
: 2.5.2024
: 9.4.2025
: Árnason Faktor ehf.
: 6
: 14.3.2025
: 9.4.2026
: Árnason Faktor ehf.